Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional study.

Abella E, Trigueros M, Pradenas E, Muñoz-Lopez F, Garcia-Pallarols F, Ben Azaiz Ben Lahsen R, Trinité B, Urrea V, Marfil S, Rovirosa C, Puig T, Grau E, Chamorro A, Toledo R, Font M, Palacín D, Lopez-Segui F, Carrillo J, Prat N, Mateu L, Clotet B, Blanco J, Massanella M, VAC-COV-GM-HMAR, KING Cohort Extension and CoronAVI@S studies

Open source

DOI: 10.26508/lsa.202201479
Published: 2022 Aug 12
Container: Life science alliance
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.26508/lsa.202201479,
  title = {Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional study.},
  author = {Abella E and Trigueros M and Pradenas E and Muñoz-Lopez F and Garcia-Pallarols F and Ben Azaiz Ben Lahsen R and Trinité B and Urrea V and Marfil S and Rovirosa C and Puig T and Grau E and Chamorro A and Toledo R and Font M and Palacín D and Lopez-Segui F and Carrillo J and Prat N and Mateu L and Clotet B and Blanco J and Massanella M and VAC-COV-GM-HMAR, KING Cohort Extension and CoronAVI@S studies},
  year = {2022},
  journal = {Life science alliance},
  doi = {10.26508/lsa.202201479},
  url = {https://doi.org/10.26508/lsa.202201479}
}

RIS

TY  - JOUR
TI  - Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional study.
AU  - Abella E
AU  - Trigueros M
AU  - Pradenas E
AU  - Muñoz-Lopez F
AU  - Garcia-Pallarols F
AU  - Ben Azaiz Ben Lahsen R
AU  - Trinité B
AU  - Urrea V
AU  - Marfil S
AU  - Rovirosa C
AU  - Puig T
AU  - Grau E
AU  - Chamorro A
AU  - Toledo R
AU  - Font M
AU  - Palacín D
AU  - Lopez-Segui F
AU  - Carrillo J
AU  - Prat N
AU  - Mateu L
AU  - Clotet B
AU  - Blanco J
AU  - Massanella M
AU  - VAC-COV-GM-HMAR, KING Cohort Extension and CoronAVI@S studies
PY  - 2022
JO  - Life science alliance
DO  - 10.26508/lsa.202201479
UR  - https://doi.org/10.26508/lsa.202201479
ER  -

APA

E, A., M, T., E, P., F, M., F, G., R, B. A. B. L., B, T., V, U., S, M., C, R., T, P., E, G., A, C., R, T., M, F., D, P., F, L., J, C., N, P., L, M., B, C., J, B., M, M., & studies, V. K. C. E. A. C. (2022). Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional study.. Life science alliance. https://doi.org/10.26508/lsa.202201479

Source records

pubmed · retrieved 2026-09-25T11:16:26.402Z